Johns Hopkins Taps C-tasc for Clinical Study Data Management
Amy DeZern, MD, MHS, provides clinical insights on the first-line treatment of patients with lower-risk MDS and symptomatic anemia. Dr Levy on Unanswered Questions Regarding the Mechanism of Action of ADCs in NSCLC ByBenjamin Levy, MD
Johns Hopkins University Home Home Profiles Research units Research output Search by expertise, name or affiliation Practical Clinical Trials: Increasing the Value of Clinical Research for Decision Making in Clinical and Health PolicySean R. Tunis, Daniel B. Stryer, Carolyn M. ClancyResearc...
A novel treatment for leukemias and lymphomas that arise from immune system T cells, developed by investigators at the Johns Hopkins Kimmel Cancer Center and its Ludwig Center and Lustgarten Laboratory, was found to be effective at killing these cancers in mice bearing human T-...
Up-to-date Coronavirus COVID-19 guidance for physicians & pharmacists from Johns Hopkins ABX. Disease spectrum, testing, and clinical trials for vaccines, remdesivir, dexamethasone discussed.
Theory of evidence and clinical trials: Steven N. Goodman Johns Hopkins University, Baltimore, Maryland(S03)doi:10.1016/0197-2456(87)90150-4ELSEVIERControlled Clinical Trials
IMAGE Study: Personalized Molecular Profiling in Cancer Treatment at Johns HopkinsBone and Cancer FoundationBone & Cancer Foundation
ERT, Johns Hopkins University and the University of Washington Expand Study on Effects of Home-Health Monitoring on Exacerbations of Cystic Fibrosis
Disaster prevention and recovery in the management of clinical trials data: Joseph Canner Johns Hopkins School of Public Health, Baltimore, Maryland(P25)doi:10.1016/0197-2456(87)90136-XELSEVIERControlled Clinical Trials